Orion Corporation Updates on Managers' Transactions
![Orion Corporation Updates on Managers' Transactions](https://investorshangout.com/images/blog/investors-hangout-newswire.jpg)
Orion Corporation: Managers’ Transactions Report
Orion Corporation has provided disclosure under the Market Abuse Regulation (EU) No 596/2014, detailing transactions in shares and linked securities executed by managers and closely associated persons.
Details of the Transaction
The transaction notification pertains to Satu Ahomäki, an Other Senior Manager at Orion Corporation. The initial notification is registered under reference number 75121/4/4.
Transaction Summary
The specific transaction occurred on August 21. All transactions were conducted at NASDAQ HELSINKI LTD (XHEL) involving shares of Orion Corporation with the ISIN code FI0009014377.
Nature and Details of Transactions
The nature of the transaction includes disposals, with multiple transactions reported. In total, 84 transactions were executed, with various volumes and prices as detailed below:
Transaction details include volumes from 1 to 267 at unit prices ranging from 46.75 EUR to 46.81 EUR.
Aggregated transactions reveal a total volume of 5000 shares with a volume-weighted average price of 46.75959 EUR.
About Orion Corporation
Orion Corporation is a renowned Finnish pharmaceutical company that has contributed to advancements in healthcare for over a century. The company engages in the development, manufacture, and marketing of both human and veterinary pharmaceuticals alongside active pharmaceutical ingredients.
Core Areas of Focus
Orion has a wide-ranging portfolio that includes both proprietary and generic medicines, as well as consumer health products. Their research and development primarily target oncology and pain management.
Market Position and Performance
Orion's proprietary products are utilized for treating various conditions, including cancer, neurological, and respiratory diseases. The company's net sales for the year reached EUR 1,190 million, employing approximately 3,600 individuals at year-end.
Leadership Team
Key members of the Orion Corporation leadership include:
- Liisa Hurme - President and CEO
- Olli Huotari - SVP, Corporate Functions
Contact Information
For further inquiries, please contact:
Orion Corporation Communications
Orionintie 1A, FI-02200 Espoo, Finland
Frequently Asked Questions
1. What is the significance of the managers' transactions report?
The report provides transparency on trading activities executed by management, aligned with regulatory requirements to ensure market integrity.
2. How many transactions did Satu Ahomäki execute?
Satu Ahomäki executed a total of 84 transactions involving share disposals within the designated period.
3. What was the average price of shares disposed of in these transactions?
The volume-weighted average price of the disposed shares was 46.75959 EUR.
4. What areas does Orion Corporation focus on in its R&D?
Orion primarily focuses on oncology and pain management within its pharmaceutical research and development efforts.
5. How can one contact Orion Corporation for more information?
Orion Corporation can be contacted through their communications office located at Orionintie 1A, FI-02200 Espoo, Finland.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/